HealthQuill Articles by: HealthQuill
AstraZeneca, Daiichi’s breast cancer drug trial results show improvement in progression-free survival
Health Research

Research reveals first child after age 30 increases breast cancer risk by over 40%

HQ Team August 18, 2025: Research finds that women who have their first child after age 30 face a 40% to 45% higher

Read More
The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer.
Drugs Health

Implant TAR-200 eliminates bladder cancer in over 80% of high-risk cases in trials

HQ Team August 18, 2025: An implant called TAR-200 has shown remarkable results in treating high-risk bladder cancer. According to a recent Phase

Read More
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in people born in 1990 than in 1995, a study reveals.
Drugs Pharma Research

Immunotherapy drug shows promising results against metastatic cancers

HQ Team August 16, 2025: Phase I clinical trial of the CD40 agonist antibody drug 2141-V11, developed by Rockefeller University’s Jeffrey V. Ravetch

Read More
Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved by the FDA for people between 18 and 65 years.
Health Medical

Medical journal refuses to retract vaccine study as demanded by US health secretary

HQ Team August 14, 2025: The Annals of Internal Medicine has refused to retract a recent study that refuted any connection between aluminum

Read More
Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder (PTSD).
Uncategorized

ADHD medication linked to lower risk of suicidal behaviour, study finds

August 14, 2025: A new study conducted by researchers at the University of Southampton in the UK and the Karolinska Institute in Sweden

Read More
Bristol Myers Squibb, a New Jersey-based drugmaker, announced it has met its primary goal of improved overall survival for its investigational therapy to treat liver cancer.
Uncategorized

Bayer and Kumquat Biosciences ink $1.3 billion deal to develop cancer inhibitor

HQ Team August 13, 2025: Bayer and Kumquat Biosciences, a clinical-stage biotech, announced an exclusive global license and collaboration agreement worth $1.3 billion

Read More
Semaglutide based weightloss drugs tied to increased suicide risk in a new study
Health Research

Researchers identify natural alternative to Ozempic: Promising weight loss option

HQ Team August 12, 2025: Researchers from Jiangnan University in China have discovered a potential natural alternative to Ozempic, a popular GLP-1 receptor

Read More
Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to cancer spreading faster, according to a study by researchers at the University of Copenhagen.
Drugs Health

New pancreatic cancer vaccine shows promise in preventing recurrence in trial-1

HQ Team August 12, 2025: A new study published in the journal Nature Medicine has shown promising results for an experimental vaccine, ELI-002

Read More
Climate Research

Lightning kills 320 million trees annually, climate change will escalate toll further

HQ Team August 12, 2025: A study published in the journal Global Change Biology has revealed that lightning kills approximately 320 million trees

Read More
The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due to the potential risk of infections.
Health

FDA approves VIZZ eye drops: A new option for presbyopia

HQ Team August 11, 2025: The US Food and Drug Administration (FDA) has granted approval to VIZZ (aceclidine ophthalmic solution 1.44%), an innovative

Read More